Form 10-K
Teva: The Road To Perdition Has Turned Into A Path Towards Redemption (NYSE: TEVA) | Seeking Alpha
Rough Day For US$ Credit, With Much Higher Yields And Wider Synthetic Spreads | ϕpost: News & Analyses of Capital Markets
Investors question green tint of Teva's $5bn sustainability bond | Financial Times
S&P downgrades Teva, pushing credit rating further into junk territory - Business - Haaretz.com
Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers - Track Live Bond Prices Online with BondEValue App -
Teva – GlobalStockPicking.com
FactEntry (@FactEntry) / Twitter
Drug company attorneys cross-examine witness, Teva exec explains 'rudimentary' suspicious order monitoring system in opioid trial | News | herald-dispatch.com
Securities Finance November 2021 Snapshot | IHS Markit
Securities Finance December 2021 Snapshot | IHS Markit
Teva (circa 20 bond in Usd, Eur, Chf) 2.8% 2023 US88167AAD37, 3.15% 2026 US88167AAE10, 6.15% 2036 US88163VAD10 | Page 20 | Quelli Che Investono
Teva (circa 20 bond in Usd, Eur, Chf) 2.8% 2023 US88167AAD37, 3.15% 2026 US88167AAE10, 6.15% 2036 US88163VAD10 | Page 6 | Quelli Che Investono
Teva: The Road To Perdition Has Turned Into A Path Towards Redemption (NYSE: TEVA) | Seeking Alpha
US88167AAE10 Institutional Ownership - Teva Pharmaceutical Fin Neth 10/01/ 2026 3.150 Bond
Investors question green tint of Teva's $5bn sustainability bond | Financial Times
Paradise Lost: Teva now a fallen angel after Moody's cut to junk | IFR
Teva (circa 20 bond in Usd, Eur, Chf) 2.8% 2023 US88167AAD37, 3.15% 2026 US88167AAE10, 6.15% 2036 US88163VAD10 | Page 10 | Quelli Che Investono
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
Prospectus
DEF 14A
The Perfect Storm – Teva – Part 1 – GlobalStockPicking.com
Teva: The Road To Perdition Has Turned Into A Path Towards Redemption (NYSE: TEVA) | Seeking Alpha
Teva Pharmaceutical Stock: Prepare For Takeoff (NYSE:TEVA) | Seeking Alpha
USD Cash Spreads Widen But Bonds Rise With Lower Rates Across The Curve | ϕpost: News & Analyses of Capital Markets
Jubilant Pharma – An Indian Company with Focus in North America (Bond Express New Member) | Bondsupermart
Investors question green tint of Teva's $5bn sustainability bond | Financial Times
-png.png "Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers - Track Live Bond Prices Online with BondEValue App -")
Macro; Rating Changes; New Issues; Talking Heads; Top Gainers and Losers - Track Live Bond Prices Online with BondEValue App -
Final Prospectus Supplement
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
